• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Integrated Palliative Care for Patients Referred for Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Service Evaluation.

作者信息

Williams Rebekah, Droney Joanne, Nicholson Emma, Gonzalez Arias Carlos, Ellard Rose, Bradley Nathalie, Maycock Celvin, Halley Angela

机构信息

Symptom Control and Palliative Care Department, The Royal Marsden Hospital, London, United Kingdom; Haematology Department, The Royal Marsden Hospital, Sutton, United Kingdom.

Symptom Control and Palliative Care Department, The Royal Marsden Hospital, London, United Kingdom; Haematology Department, The Royal Marsden Hospital, Sutton, United Kingdom.

出版信息

J Pain Symptom Manage. 2024 Feb;67(2):e157-e159. doi: 10.1016/j.jpainsymman.2023.11.002. Epub 2023 Nov 8.

DOI:10.1016/j.jpainsymman.2023.11.002
PMID:37949255
Abstract
摘要

相似文献

1
Integrated Palliative Care for Patients Referred for Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Service Evaluation.嵌合抗原受体（CAR）T细胞治疗转诊患者的综合姑息治疗：一项服务评估。
J Pain Symptom Manage. 2024 Feb;67(2):e157-e159. doi: 10.1016/j.jpainsymman.2023.11.002. Epub 2023 Nov 8.
2
A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: Recommendations for service development and implications for palliative care teams.CAR-T 疗法患者和照护者体验的定性服务评估：对服务发展的建议和对姑息治疗团队的影响。
Palliat Med. 2023 Feb;37(2):215-220. doi: 10.1177/02692163221138880. Epub 2022 Nov 25.
3
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center.门诊嵌合抗原受体（CAR）T细胞疗法的安全性与可行性：来自三级医疗中心的经验
Bone Marrow Transplant. 2022 Jun;57(6):1025-1027. doi: 10.1038/s41409-022-01664-z. Epub 2022 Apr 11.
4
Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple Myeloma.多发性骨髓瘤嵌合抗原受体 T 细胞治疗全程的护理。
Semin Oncol Nurs. 2023 Dec;39(6):151505. doi: 10.1016/j.soncn.2023.151505. Epub 2023 Sep 24.
5
Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma.嵌合抗原受体 (CAR) T 细胞疗法治疗胶质母细胞瘤。
Neuromolecular Med. 2022 Mar;24(1):35-40. doi: 10.1007/s12017-021-08689-5. Epub 2021 Oct 19.
6
New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometry.嵌合抗原受体 T 细胞（CAR-T）治疗及相关流式细胞术的新方向
Cytometry B Clin Cytom. 2020 Jul;98(4):299-327. doi: 10.1002/cyto.b.21880. Epub 2020 Apr 30.
7
Immunotherapy for lung cancer: Focusing on chimeric antigen receptor (CAR)-T cell therapy.肺癌的免疫治疗：聚焦嵌合抗原受体（CAR）-T 细胞疗法。
Curr Probl Cancer. 2022 Feb;46(1):100791. doi: 10.1016/j.currproblcancer.2021.100791. Epub 2021 Sep 3.
8
Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell Therapy.缩小差距：早期过渡与混合护理模式以改善嵌合抗原受体T细胞疗法的可及性
Transplant Cell Ther. 2023 Jun;29(6):399-402. doi: 10.1016/j.jtct.2023.03.021. Epub 2023 Mar 27.
9
Utilization of Chimeric Antigen Receptor T-cell Therapy in Adults.嵌合抗原受体 T 细胞疗法在成人中的应用。
Semin Oncol Nurs. 2019 Oct;35(5):150930. doi: 10.1016/j.soncn.2019.08.009. Epub 2019 Sep 25.
10
Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma.嵌合抗原受体（CAR）T细胞疗法治疗胶质母细胞瘤
Cancer Treat Res. 2022;183:161-184. doi: 10.1007/978-3-030-96376-7_5.

引用本文的文献

1
Health-Related Values Discussions With Patients Receiving Allogeneic and Autologous Stem Cell Transplant and Chimeric Antigen Receptor Therapy (CAR-T): Implementation of an Early Nurse Practitioner-Led Primary Palliative Care Intervention.与接受异基因和自体干细胞移植及嵌合抗原受体疗法（CAR-T）的患者进行的健康相关价值观讨论：早期由执业护士主导的初级姑息治疗干预措施的实施
J Hosp Palliat Nurs. 2025 Aug 22. doi: 10.1097/NJH.0000000000001148.
2
The patient and caregiver experience of CAR T-cell therapy: A qualitative analysis.嵌合抗原受体T细胞疗法的患者及照护者体验：一项定性分析
J Psychosoc Oncol. 2025 Jan 30:1-11. doi: 10.1080/07347332.2025.2460060.